Showing results (171-180 of 260) with videos related to
Sort By:
Pageof 26
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 29, 2023
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?Milo Gatti, Matteo Rinaldi, Luciano Potena, et al.Urologia|July 14, 2015
Urological infections due to multidrug-resistant bacteria: what we need to know?Tommaso Cai, Cosimo De Nunzio, Andrea Salonia, et al.Pharmaceutics|December 28, 2021
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?Pier Giorgio Cojutti, Alessia Carnelutti, Davide Lazzarotto, et al.Infectious Disease Reports|February 24, 2022
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug MonitoringPier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, et al.Paediatric Drugs|November 6, 2024
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized MedicineRiccardo Masetti, Gianluca Bossù, Edoardo Muratore, et al.Future Microbiology|February 26, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant EnterobacteralesTanaya Bhowmick, Rafael Canton, Federico Pea, et al.Internal and Emergency Medicine|May 30, 2014
Identification and management of invasive mycoses in internal medicine: a road-map for physiciansMarco Falcone, Ercole Concia, Ido Iori, et al.International Journal of Antimicrobial Agents|November 19, 2023
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infectionsPier Giorgio Cojutti, Milo Gatti, Nieko Punt, et al.Journal of Global Antimicrobial Resistance|June 18, 2021
Challenges in the management of chronic wound infectionsMarco Falcone, Barbara De Angelis, Federico Pea, et al.Journal of Clinical Medicine|May 13, 2026
Management of Mild to Moderate Pain from Triage to Discharge in the Emergency Department: A Multidisciplinary Delphi Consensus from the Italian Society of Emergency Medicine (SIMEU)Alessandro Riccardi, Fabio De Iaco, Elena Del Giudice, et al.Pageof 26